Ahammune Biosciences Secures $5M for Vitiligo Trials
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
- Latest
- Trending
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
Explore how U.S. states are leading AI regulation efforts, focusing on industry-specific and high-risk AI systems.
BMW's E Ink tech offers customizable car colors, set to revolutionize vehicle aesthetics by 2027 with energy-efficient designs.
Gallus unveils MatteJet, enabling cost-effective matte finishes for digital inkjet in wine labels, revolutionizing the industry.
Maryland launches $1.8M fund to expand cyber ranges, addressing cybersecurity workforce gaps with hands-on training opportunities.
Google commits $400M to Nevada tech, boosting AI and cloud services. Includes $500K donation to enhance water stewardship.
ACLU of Maryland calls for strict safeguards on police use of facial recognition, citing risks of false arrests and privacy ...
Ethereum aims for a new high with ETF launch. Rainbow chart offers a potential price range for ETH by 2025.
Star Equity enters Energy and Logistics sectors by investing in Enservco. This strategic move diversifies their portfolio.
Advanced color tech transforms e-paper's potential, shifting from zero-sum to expansive growth, reports DIGITIMES Research.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.